4 results about "Myocardial imaging" patented technology

A deep learning model for the detection of obstructive coronary artery disease (CAD) can take a set of polar maps and patient information as input, then output obstructive CAD scoring data, such as probabilities of obstructive CAD associated with various cardiac territories, as well as an attention map and a CAD scoring map. The model can operate agnostic of camera type used to capture the set of polar maps. The attention map indicates regions of the polar maps important to the deep learning process for that particular set of polar maps. The attention map and obstructive CAD scoring data can be used to generate a CAD scoring map showing CAD probability by segment on a standard 17-segment model of a left ventricle. The attention map and / or CAD scoring map can act as easily explainable tools for interpreting the results of a myocardial perfusion imaging study.

Systems and methods are disclosed for automatically performing motion correction in dynamic positron emission tomography scans, such as dynamic positron emission tomography myocardial perfusion imaging studies. An automated algorithm can be used. The algorithm can use simplex iterative optimization of a count-based cost-function customized to different dynamic phases for performing frame-by-frame motion correction.

The application provides a myocardial imaging method and an ultrasonic imaging device. The method comprises: acquiring a plurality of ultrasonic images of a heart of a target object during a myocardial perfusion process; acquiring an electrocardiogram signal of the target object during the myocardial perfusion process; identifying a position of a heart phase in the electrocardiogram signal; taking an ultrasonic image corresponding to the heart phase as a key frame image of the heart phase; generating an electrocardiogram pattern representing the electrocardiogram signal; marking the position of the first heart phase in the electrocardiogram signal on the electrocardiogram pattern; detecting whether a reset operation of the first heart phase is received by a user; if the reset operation is received, setting the position of the first heart phase in the electrocardiogram signal, re-determining the key frame image; and if the reset operation is not received, keeping the key frame image unchanged. The myocardial imaging method and the ultrasonic imaging device allow the user to manually adjust the position of the heart phase, so that a heart phase more in line with the user's expectation can be obtained.

Embodiments of the present disclosure relate to compositions and methods for performing positron emission tomography (PET), and more particularly, to compositions and methods for use in selected imaging techniques (e.g., studying myocardial physiology). 18 Provided are compositions and methods for the development and use of F-based PET tracers. In particular, as disclosed herein, at the tracer level, [ 18 [F]F-AraG has the potential to be used in many emerging PET methodologies, including those designed for cardiac and / or mitochondrial activity imaging. 18 The use of [F]F-AraG has demonstrated significant benefits over conventional methods in many distinct applications, including the observation of selected physiological phenomena (e.g., myocardial perfusion, myocardial viability, and cardiac inflammation). 18 The method of the present invention provides significant advantages over F-labeled tracers. 18 F]F-AraG, including those designed to monitor patients.